[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.196.37. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Observation
October 20, 2008

The Stiff Skin SyndromeCase Series, Differential Diagnosis of the Stiff Skin Phenotype, and Review of the Literature

Author Affiliations

Author Affiliations: The Permanente Medical Group, San Francisco, California (Dr Liu), and Departments of Pathology (Dr McCalmont), Dermatology (Drs McCalmont, Frieden, Williams, Connolly, and Gilliam), and Pediatrics (Drs Frieden, Williams, and Gilliam), University of California, San Francisco.

Arch Dermatol. 2008;144(10):1351-1359. doi:10.1001/archderm.144.10.1351
Abstract

Background  Stiff skin syndrome is a sclerodermalike disorder that presents in infancy or early childhood with rock-hard skin, limited joint mobility, and mild hypertrichosis in the absence of visceral or muscle involvement, immunologic abnormalities, or vascular hyperreactivity.

Observations  We describe 6 children who fit criteria for stiff skin syndrome. A review of the clinical range of this disorder and discussion of the differential diagnosis is presented. The age at onset in our cases ranged from infancy to 6 years of age. Stony-hard skin was noted mostly on the thighs, buttocks, and lower back with shoulder and arm involvement in 2 cases. There was associated hypertrichosis in 3 of 6 cases. Extracutaneous manifestations consisted primarily of joint restriction, and several patients had resulting postural and thoracic wall irregularities. Histopathologically, our cases showed areas of fascial sclerosis or showed increased fibroblast cellularity with thickened, sclerotic, horizontally oriented collagen bundles in the deep reticular dermis and/or subcutaneous septa without associated inflammation.

Conclusions  Stiff skin syndrome is characterized by an early, insidious onset of stony-hard skin, often with associated contracturelike joint restriction, hypertrichosis, and postural and thoracic wall abnormalities. Supportive histopathologic findings consisting of either fascial sclerosis or increased fibroblast cellularity with sclerotic collagen bundles in the deep reticular dermis and/or subcutaneous septa may help to confirm this diagnosis.

Stiff skin syndrome (SSS) is a sclerodermalike disorder characterized by stony-hard skin, limited joint mobility, and mild overlying hypertrichosis. We report 6 cases of SSS, emphasizing the clinical presentations, histopathologic features, and differential diagnosis of this rare disorder. Cases 3 to 6 are presented briefly to highlight the salient features of each case.

REPORT OF CASES
CASE 1

A 6-year-old white boy presented with thickened skin since infancy. His parents noted thickened skin on his right thigh at 1 year of age that subsequently spread to the right buttocks, trunk, and shoulder and recently to the left thigh. He began walking at 10 months of age with a limp that never resolved. His right leg was notably wider in diameter than his left leg by age 2½ years. He had progressively impaired mobility and required physical therapy and a wheelchair to assist in his ambulation. He has had no visceral symptoms, no Raynaud phenomena, and no intellectual impairment. His medical history included asthma, frequent ear infections, and a patent ductus arteriosus. There were no affected family members.

On physical examination, he had a very dense, woody, ill-defined induration encircling his right thigh to just above the patella extending to his right buttocks, back, and shoulder. The left thigh and buttocks were involved to a lesser extent from the iliac crest down through the lateral and posterior thigh to below the knee joint. He had restricted range of motion of his hips and knees and a slightly protruding barrel chest, and his thorax was thinned with respect to his arm girdle. He had hypertrichosis in his lumbosacral area (Figure 1A).

Figure 1.
Stiff skin syndrome case 1. A, A white male patient with dense, woody, ill-defined induration of the skin on his back, associated with hypertrichosis of the lumbosacral area (photograph taken at age 14 years). B, Histopathologic findings: the fascia is thickened and sclerotic with slightly accentuated overall cellularity (hematoxylin-eosin, original magnification ×200).

Stiff skin syndrome case 1. A, A white male patient with dense, woody, ill-defined induration of the skin on his back, associated with hypertrichosis of the lumbosacral area (photograph taken at age 14 years). B, Histopathologic findings: the fascia is thickened and sclerotic with slightly accentuated overall cellularity (hematoxylin-eosin, original magnification ×200).

His laboratory evaluations included a negative antinuclear antibody and normal skeletal films. A thoracic computed tomography scan and magnetic resonance imaging of the abdomen, pelvis, and lower extremities only revealed a nonspecific soft tissue enhancement. Findings from pulmonary functional studies were normal. A deep fascial biopsy revealed a fascial thickening and sclerosis with only a subtle increase in overall cellularity (Figure 1B). There was a subtle increase in deep dermal cellularity as well. The superficial dermis and epidermis were normal, and there was little to no increase in interstitial mucin in the dermis.

The progression of his skin disease was followed using clinical drawings that delineated regions affected by skin thickening. During the first 6 months of follow-up, the areas of clinical induration progressed to involve more of the upper back, right lateral arm, neck, abdomen, and lower legs bilaterally. After consultation with the pediatric rheumatology service, treatment with monthly intravenous pulses of methylprednisolone (20 mg/kg) for 3 months along with weekly doses of methotrexate, 25 mg, subcutaneously was initiated. One year later, no further areas of progression were observed and some of the more mildly affected areas appeared to be softening. However, long-term follow-up examination at age 15 years revealed that the patient's skin disease continued to slowly progress to involve new areas despite trials of other therapeutic modalities, including psoralen with UV-A light and oral penicillamine.

CASE 2

An 8-year-old Hispanic girl presented with a skin lesion on her left lateral thigh that had been present for 1 to 2 years. Her father reported that the lesion was initially small but had been gradually widening out of proportion to her growth. There was no associated pain or pruritus. The child was otherwise healthy with normal growth and development, and there was no family history of similar skin conditions or autoimmune disease.

On skin examination, she had a 30 × 10-cm area of thickened, sclerotic skin located on the left thigh with associated hyperpigmentation and hypertrichosis (Figure 2A). At the periphery of the lesion, deep nodular components could be palpated. The lesion extended from her left flank and hip along the lateral thigh and involved the left posterior calf.

Figure 2.
Stiff skin syndrome case 2. A, An 8-year-old Hispanic female patient with a 1- to 2-year history of a 30 × 10 cm area of “rock-hard” skin located on the left lateral thigh with associated hyperpigmentation and hypertrichosis. With palpation, the skin lesion feels deeply sclerotic and nodular components are appreciable at the superior aspect of the lesion. B, Histopathologic findings: there are compact collagen bundles with a horizontal and diagonal orientation that course through the deep reticular dermis and subcutis; some of the compact individual collagen bundles have a tendonlike quality by conventional microscopy (hematoxylin-eosin, original magnification ×40).

Stiff skin syndrome case 2. A, An 8-year-old Hispanic female patient with a 1- to 2-year history of a 30 × 10 cm area of “rock-hard” skin located on the left lateral thigh with associated hyperpigmentation and hypertrichosis. With palpation, the skin lesion feels deeply sclerotic and nodular components are appreciable at the superior aspect of the lesion. B, Histopathologic findings: there are compact collagen bundles with a horizontal and diagonal orientation that course through the deep reticular dermis and subcutis; some of the compact individual collagen bundles have a tendonlike quality by conventional microscopy (hematoxylin-eosin, original magnification ×40).

Laboratory evaluations included negative findings for antinuclear antibodies and anti–double-stranded DNA as well as a normal complete blood cell count, erythrocyte sedimentation rate, and C-reactive protein level. An excisional biopsy from the involved skin revealed deep dermal and subcutaneous sclerosis with thickened, horizontally arranged collagen bundles with diminished spaces between them. There was a slight increase in spindled cellularity throughout the reticular dermis with the absence of an associated lymphocytic or plasmacytic infiltrate. The intervening fatty lobules appeared normal (Figure 2B). These histopathologic findings were interpreted as consistent with SSS.

The patient returned for follow-up examination 1 year after her initial presentation, at which time progression of her disease was noted. The skin involvement had extended to include her hip and waist, encompassing an area of 25 × 58 cm. She complained of limitation of her range of motion and pain with exercise. A physical therapy evaluation had been requested after the first visit, and the family had not followed through with this. Physical therapy was again recommended with the addition of ibuprofen for pain, and the patient has since been lost to follow-up.

CASE 3

A 6-year-old white girl with an unremarkable medical and family history presented with firm skin that started on the right leg for 1 year. She had thickened skin with overlying hyperpigmentation that involved her lower hip girdle, lower back, lateral thighs, and entire legs. She had a pseudohypertrophic stance and toe-walked with her right leg. She had a protuberant chest, retracted arms, and thin, atrophic shoulders. There was also increased dense hair growth over the lumbosacral area. A punch biopsy revealed a subtle increase in density of fibrocyte nuclei and a marked increase in interstitial mucin in the deep reticular dermis. The fascia was not visualized.

CASE 4

A 9-year-old girl presented with a 6-year history of indurated skin starting in the left deltoid. She had not responded to therapy with topical calcipotriene, triamcinolone, and betamethasone dipropionate. She had a brother with a similar lesion on the buttock, but he had not been examined by us. The involved areas of her skin had a sensation of skin “tightness” and occasional tenderness after physical exertion. She had markedly thickened skin involving the left shoulder and arm area, the left lumbar back, and the right back. Multiple biopsies finally revealed thickened, sclerotic collagen bundles in horizontal array in the deep reticular dermis and superficial subcutaneous septa without inflammation or distortion of the adnexa. Dermal and subcutaneous septal cellularity was slightly increased. The fascia was not visualized.

CASE 5

A 2-year-old girl presented with a growing lesion on her left buttock that had been present since birth. She had an otherwise unremarkable medical and family history. The lesion was asymptomatic and did not interfere with ambulation. She had a deep induration on the lateral aspect of the left buttock with overlying hypertrichosis. Skin biopsy results showed broadened and elongated collagen bundles in a haphazard arrangement in the mid to deep reticular dermis. There were also clusters of lipocytes in the dermis.

CASE 6

A 7-year-old white girl presented with thick skin on the right buttock for 4 years. A skin biopsy specimen had previously shown dermal fibrosis without inflammation, and she was treated with topical calcipotriene and clobetasol ointments for presumed morphea. She experienced minimal softening of her skin in that area according to parental report. She had an otherwise unremarkable medical and family history. There was a 4 × 5-cm, ill-defined, indurated plaque of deep sclerosis that involved the right buttock, the lower back, and the right hip. She had no limitation of range of motion at the right hip. An excisional skin biopsy specimen showed abnormally horizontally oriented, thickened collagen bundles with a subtle increase in fibrocytes in the deep reticular dermis. The elastic tissue was normally preserved, and fascia was not observed in the sections.

COMMENT

Stiff skin syndrome is a rare disorder originally described by Esterly and McKusik.1 It is characterized by stony-hard skin, limited joint mobility, and mild overlying hypertrichosis. Jablonska et al2 further characterized this condition as a generalized, noninflammatory fascial disorder in the absence of visceral involvement, muscle involvement, immunologic abnormalities, or vascular hyperreactivity and proposed the name “congenital fascial dystrophy.” At least 37 cases of SSS have been published since the initial report by Esterly and McKusik.121Table 1 summarizes the clinical features in these 37 published cases of SSS in addition to the 6 cases presented herein.

Table 1. 
Prevalence of Key Features in 37 Reported Cases of Stiff Skin Syndrome With the Addition of the Present 6 Cases
Prevalence of Key Features in 37 Reported Cases of Stiff Skin Syndrome121 With the Addition of the Present 6 Cases
CLINICAL FEATURES

The cutaneous findings present in infancy or in early childhood with rock-hard skin bound firmly to the underlying tissues that is most prominent in areas with abundant fascia such as on the buttocks and thighs.3 The overlying skin can be normal in appearance or may have mild hypertrichosis and hyperpigmentation overlying the affected areas of skin. Our patients had cutaneous involvement primarily or exclusively in the pelvic and shoulder girdle areas. The indurated skin felt like a well-demarcated, large, sometimes nodular subcutaneous tumor. All of the cases have had an insidious onset in infancy or early childhood.

Extracutaneous features of SSS include contractures, especially of the large joints, often resulting in scoliosis, a tiptoe gait, and a narrow thorax in relation to the arm girdle. Several reported cases have had associated restrictive pulmonary changes and growth retardation. Notably lacking are visceral, bone, or muscular involvement; immunologic abnormalities; vascular disturbances; or mucopolysacchariduria.4

The disease is slowly progressive and nonfatal. A genetic basis has been suggested by the reports of other affected family members1,58 and/or evidence of associated consanguinity.1,5,6,9 Therapy thus far has been limited to supportive and rehabilitative care. In our cases, joint restriction was common but not universal. Postural and thoracic wall irregularities occurred sporadically. None of our cases had other associated abnormalities. All of our cases were isolated with the possible exception of case 4, whose family reported a sibling with a similar skin condition, which was not brought to medical attention.

HISTOPATHOLOGIC FEATURES

Several histologic patterns have been described in previous reports. Early reports described increased dermal mucin1,5 and large, bizarre fibroblasts that stained metachromatically with toluidine blue.5 Jablonska et al2 described underlying fascial thickening “four times beyond normal” with “amianthoid-like” collagen fibers and bundles composed of incompletely organized microfibrils. Several subsequent reports confirmed a thickened fascia,6,10,1316,21 but others7,17,18 reported normal fascia. One of our patients (case 1) had a biopsy of the fascia, which revealed fascial sclerosis. In the remaining 5 cases, the diagnosis was microscopically supported via deep incisional or punch biopsies that did not include the fascia. In one of our patients (case 2), the biopsy revealed increased cellularity and an increase in interstitial mucin in the deep reticular dermis. These findings, in conjunction with the characteristic postural and thoracic wall changes, led to the diagnosis of SSS. In the remaining 4 cases, biopsy specimens showed thickened, sclerotic collagen bundles in the deep reticular dermis and/or subcutaneous septa with no inflammation or distortion of adnexa. The collagen was usually horizontally oriented with diminished spaces between them, although 1 case exhibited a haphazard arrangement in the mid to deep reticular dermis. Slightly increased cellularity was present in 3 of these 4 cases and 5 of the 6 total cases. Several patients needed repeated deeper biopsies performed because prior superficial biopsies were nondiagnostic. Possibly, SSS exhibits a spectrum of histopathologic findings, with interstitial mucin representing early disease and the deep dermal sclerosis signifying a later stage.

DIFFERENTIAL DIAGNOSIS

Several entities have clinical features that resemble SSS. Scleredema, in particular, can have many overlapping features with SSS. Scleredema results in nonpitting edema due to mucin in the dermis. It typically presents with skin tightness and induration beginning on the neck or face and spreading symmetrically to involve the arms, shoulders, back, and chest.22 It may have an acute onset following an upper respiratory tract infection or an insidious onset without preceding infection, with or without diabetes mellitus. Classically, it is a disease of adults, but several pediatric cases have been reported. Microscopically, there is increased mucin deposition in the reticular dermis as well as broadening of collagen bundles, but the bundles are separated by fenestrations.2325 Sclerotic fascia has not been reported in scleredema.

Several features can help differentiate SSS and scleredema. In SSS, disease is centered on or around the pelvic and shoulder girdle, whereas scleredema is centered on the face, head, neck, and back24 and with rare exception25 only involves the pelvic or shoulder girdle with concomitant involvement of the face, neck, or upper back.24 Joint restriction, although common in SSS, is rare in scleredema and is more often due to a “bulk” effect of the thick skin usually affecting the eyelids, neck, mouth, and shoulder.18,2629 The skin stiffness in SSS, in our experience, is often well demarcated, uneven, or lumpy and may not involve an entire anatomic unit, while the stiffness in scleredema is more uniform, typically encompassing an entire involved anatomic unit. The abrupt onset often seen in scleredema is not a feature of SSS. The histopathologic features overlap, but increased fibroblast cellularity, thickened collagen bundles in a horizontal arrangement, and diminished spaces between individual bundles, if present, can help differentiate biopsy results of SSS from scleredema. Typically in scleredema, the collagen bundle pattern is nearly normal.

Recently, 2 cases with overlapping features of both scleredema and SSS were published as a diagnostic dilemma.18 One patient had a 3-day history of right leg swelling, diffuse induration of the right flank, waist, and entire right leg from ankle to hip, and histopathologic findings that demonstrated bundles of irregular dense collagen extending deep into the sweat ducts and separated by mucin and a normal fascia. The abrupt onset and diffuse uniform involvement in this case make scleredema, albeit in an atypical distribution, the most likely diagnosis. The second case was a 9-year-old girl with a 5-year history of progressive firmness on the right thigh, torso, shoulder, and bilateral buttocks, with loss of range of motion of the right knee and hip and an uneven plaquelike induration of the right thigh and flank. Findings from histopathologic examination demonstrated slight separation of thickened collagen bundles (suggestive of scleredema) but also an increased fibrocyte density favoring classification as SSS, and these features, particularly with joint contracture and the uneven, irregular induration on the right leg, are those of SSS.

Cases of SSS are often initially diagnosed as sclerodermatomyositis, systemic sclerosis, or localized scleroderma. Sclerodermatomyositis is an overlap syndrome with features of dermatomyositis and systemic sclerosis30 that typically presents with arthralgias, arthritis, sclerodermoid skin lesions, and joint restriction. Features that distinguish this entity from SSS are evidence of muscle involvement (eg, elevated serum muscle enzyme level and abnormal electromyography), autoantibodies, and vascular hyperreactivity. Systemic sclerosis is very rare in childhood and has many features including “hidebound” skin changes in the hands and face, Raynaud phenomenon, periungual telangiectasias, and immunologic abnormalities that help distinguish it from SSS.2 Localized scleroderma (morphea) tends to have a later onset as well as more localized and asymmetric indurations and alterations of the skin.2

Deep morphea, a form of localized scleroderma, must also be distinguished from SSS. This can sometimes be difficult, given the clinical similarities between the 2 disorders. However, the histopathologic findings of deep morphea (as well as those of systemic sclerosis and localized scleroderma) are distinct from those of SSS. In deep morphea, there is typically a lymphocytic or lymphoplasmacytic infiltrate at the junction of the dermis and subcutis with abnormal, sclerotic collagen in the deep reticular dermis or subcutaneous septa, and fascial involvement is exceptional. In contrast, in SSS there is typically fascial sclerosis with slightly increased fibrocyte cellularity, and thickened collagen bundles, often with a horizontal orientation, are sometimes also present in the deep reticular dermis and/or subcutaneous septa. There is characteristically no inflammation or distortion of adnexa in SSS. In addition, many of the clinical features of SSS, such as the characteristic distribution involving the pelvic area and/or shoulder girdle and the often-present hypertrichosis, are typically not observed with deep morphea. Finally, patients with SSS rarely respond to anti-inflammatory treatments compared with those with deep morphea (Table 2). Case 1 was treated with pulsed methylprednisolone sodium and methotrexate owing to relentless disease progression and a lack of therapeutic alternatives. While disease activity appeared to slow down within the first few years after treatment, long-term follow-up has demonstrated continued slow disease progression with involvement of new areas despite trials of other therapeutic modalities. While there are similarities between SSS and an infantile form of deep morphea, the clinical and histopathologic differences suggest that they are distinct entities.

Table 2. 
Treatment of Stiff Skin Syndrome in 37 Reported Cases With the Addition of the Present 6 Cases
Treatment of Stiff Skin Syndrome in 37 Reported Cases121 With the Addition of the Present 6 Cases

Early cases of SSS may resemble smooth muscle hamartomas or connective tissue nevi, both of which can present as an indurated plaque on the trunk or extremity. Histologic findings of a marked increase in smooth muscle fibers in the dermis distinguish smooth muscle hamartoma from SSS.31 Biopsy results of connective tissue nevi can demonstrate a hamartomatous proliferation of collagen or elastin or may appear as normal skin,32,33 but fascial sclerosis, sclerotic collagen bundles in the deep reticular dermis, increased interstitial mucin, or increased cellularity are not found.

Nephrogenic systemic fibrosis, formerly called nephrogenic fibrosing dermopathy, is a scleromyxedemalike fibrosing skin condition found in patients with kidney disease. Pediatric cases have been reported.34 This condition presents as extensive thickening and hardening of the skin with a peau d’orange appearance typically located on the extremities, buttocks, and trunk. Occasionally, joint contractures occur as well. Histopathologic findings demonstrate an increase in dermal fibroblasts, thickened collagen bundles with surrounding clefts, and increased mucin and elastic fibers extending through the subcutis along the septa of fatty lobules, and typically, the degree of overall dermal and subcutaneous cellularity is strikingly different than that of SSS. While there is considerable clinical overlap, a history of renal insufficiency is universally present in this entity and differentiates it from SSS.34 Recent publications suggest an association between exposure to gadolinium-containing contrast agents and subsequent development of nephrogenic systemic fibrosis.35,36

Eosinophilic fasciitis classically presents with rapidly appearing tender swelling on the arms and legs evolving into brawny induration, often following exertion.3739 Localized morphealike skin changes and joint contractures may be present, and the induration is often more distal than proximal. Hematologic abnormalities including peripheral blood eosinophilia, hypergammaglobulinemia, and elevated erythrocyte sedimentation rate are often present. Histopathologic findings demonstrate thickened fascia with a cellular inflammatory infiltrate of lymphocytes and plasma cells, with or without eosinophils. In an appropriate biopsy specimen, this entity can be readily distinguished from SSS.

Several other rare conditions can have presentations resembling SSS. The clinical and diagnostic features of these are summarized in Table 3.

Table 3. 
Rare Entities in the Differential Diagnosis of Stiff Skin Syndrome
Rare Entities in the Differential Diagnosis of Stiff Skin Syndrome
PATHOGENESIS

The pathogenesis of SSS is unclear, but proposed mechanisms include a primary fibroblast disorder resulting in increased acid mucopolysaccharide deposition in the dermis,1,5 a primary fascial dystrophy resulting in an increased accumulation of collagen,2,6 and an inflammatory process.7 It has recently been shown that the fascia in patients with SSS differs from normal fascia by an abundance of myofibroblasts and an overproduction of type VI collagen.9 Interestingly, myofibroblasts are thought to be the operative cells in extrabdominal desmoid tumors, and type VI collagen might be the material deposited in juvenile hyaline fibromatosis45 and is also overproduced in systemic scleroderma.46 Hence, there may be a cytological and biochemical overlap between some of these entities.

The tight-skin (TSK) mouse model has been advanced as an animal model for SSS.6 The TSK gene is transmitted in an autosomal dominant pattern and is located on the mouse chromosome 2.72 The heterozygous TSK mice (the homozygous state appears to be lethal) develop substantial hypertrophy of loose connective tissue, tendons, cartilage, and bone and have a tightness of the skin that makes it difficult to grasp a fold of skin on the back. Microscopically, there appears to be an abundance of acid mucopolysaccharide deposition in the dermis and hypodermis as well as a markedly thickened fascia.72 The defect appears to be an accelerated biosynthesis of collagen in the fibroblasts of TSK mice.73 Characterizing the defective gene product of the TSK mutation could well shed significant light on the pathogenesis of SSS, scleroderma, and perhaps some of the other conditions that lead to the stiff skin phenotype.

CONCLUSIONS

Stiff skin syndrome is characterized by an early, insidious onset of stony-hard, sometimes uneven induration of the skin, centering on the pelvic and/or shoulder girdle usually with contracturelike joint restriction. Hypertrichosis and postural and thoracic wall abnormalities such as a pseudohypertrophic stance, thinned thorax, broad shoulders, barrel chest, and tiptoe gait occur variably. The diagnosis is supported by histopathologic findings consisting of either fascial sclerosis or an increased fibroblast cellularity with thickened, sclerotic, usually horizontally oriented collagen bundles in the deep reticular dermis and/or subcutaneous septa with no inflammation or distortion of adnexa and no increased spaces between the bundles. The findings of increased mucin with increased fibroblast cellularity are suggestive but not diagnostic of SSS.

Back to top
Article Information

Correspondence: Amy E. Gilliam, MD, Department of Dermatology, University of California, San Francisco, 1701 Divisadero St, Third Floor, San Francisco, CA 94143-0316 (dr_amy_g@yahoo.com).

Accepted for Publication: February 19, 2008.

Author Contributions: Drs Liu and Gilliam had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Liu, Williams, Connolly, and Gilliam. Acquisition of data: Liu, Frieden, Williams, Connolly, and Gilliam. Analysis and interpretation of data: Liu, McCalmont, Frieden, Williams, and Connolly. Drafting of the manuscript: Liu. Critical revision of the manuscript for important intellectual content: Liu, McCalmont, Frieden, Williams, Connolly, and Gilliam. Statistical analysis: Liu. Administrative, technical, and material support: Liu. Study supervision: Liu, McCalmont, Frieden, Connolly, and Gilliam.

Financial Disclosure: None reported.

References
1.
Esterly  NBMcKusick  VA Stiff skin syndrome. Pediatrics 1971;47 (2) 360- 369
PubMed
2.
Jablonska  SGroniowski  JKrieg  T  et al.  Congenital fascial dystrophy—a noninflammatory disease of fascia: the stiff skin syndrome. Pediatr Dermatol 1984;2 (2) 87- 97
PubMedArticle
3.
Jablonska  SBlaszczyk  M Scleroderma-like disorders. Semin Cutan Med Surg 1998;17 (1) 65- 76
PubMedArticle
4.
Jablonska  SBlaszczyk  M Scleroderma-like indurations involving fascias: an abortive form of congenital fascial dystrophy (stiff skin syndrome). Pediatr Dermatol 2000;17 (2) 105- 110
PubMedArticle
5.
Kikuchi  IInoue  SHamada  KAndo  H Stiff skin syndrome. Pediatr Dermatol 1985;3 (1) 48- 53
PubMedArticle
6.
Jablonska  SSchubert  HKikuchi  I Congenital fascial dystrophy: stiff skin syndrome—a human counterpart of the tight-skin mouse. J Am Acad Dermatol 1989;21 (5, pt 1) 943- 950
PubMedArticle
7.
Richard  MAGrob  JJPhilip  N  et al.  Physiopathogenic investigations in a case of familial stiff-skin syndrome. Dermatology 1998;197 (2) 127- 131
PubMedArticle
8.
Singer  HValle  DRogers  JThomas  G The stiff skin syndrome: new genetic and biochemical investigations [abstract]. Birth Defects Orig Artic Ser 1977;13 (3B) 254- 255
9.
Fidzianska  AJablonska  S Congenital fascial dystrophy: abnormal composition of the fascia. J Am Acad Dermatol 2000;43 (5, pt 1) 797- 802
PubMedArticle
10.
Gilaberte  YSáenz-de-Santamaria  MCGarcia-Latasa  FJGonzalez-Mediero  IZambrano  A Stiff skin syndrome: a case report and review of the literature. Dermatology 1995;190 (2) 148- 151
PubMedArticle
11.
Bodemer  CHabib  KTeillac  DMunich  ADe Prost  Y A new case of stiff skin syndrome [in French]. Ann Dermatol Venereol 1991;118 (11) 805- 806
PubMed
12.
Bundy  SELie  K Stiff skin syndrome. Birth Defects Orig Artic Ser 1975;11 (2) 360- 361
PubMed
13.
Amoric  JCStalder  JFDavid  A  et al.  Dysmorphism in stiff skin syndrome [in French]. Ann Dermatol Venereol 1991;118 (11) 802- 804
PubMed
14.
Helm  TNWirth  PBHelm  FK Congenital fascial dystrophy: the stiff skin syndrome. Cutis 1997;60 (3) 153- 154
PubMed
15.
Roose-Thiry  BBodemer  CAmoric  J-C  et al.  Stiff skin syndrome and geleophysic dysplasia: nosological limits [abstract]? Ann Dermatol Venereol 1998;125 ((suppl 1)) IS31- IS32
16.
Lê  TPiérard  GE Stiff skin syndrome [in French]. Ann Dermatol Venereol 1989;116 (11) 807- 809
PubMed
17.
Mat  CKalayciyan  AArzuhal  N  et al.  Stiff skin syndrome: a case report. Pediatr Dermatol 2003;20 (4) 339- 341
PubMedArticle
18.
Morrell  DSChallgren  ENijhawan  A  et al.  Two cases for diagnosis: asymmetric childhood scleredema or stiff skin syndrome? Pediatr Dermatol 2003;20 (4) 350- 355
PubMedArticle
19.
Jablonska  SBlaszczyk  M Stiff skin syndrome is highly heterogenous, and congenital fascial dystrophy is its distinct subset. Pediatr Dermatol 2004;21 (4) 508- 510
PubMedArticle
20.
Pizzi-Parra  NParra  CGaray  M  et al.  Stiff skin syndrome [abstract]. Ann Dermatol Venereol 1998;125 ((suppl 1)) IS47
21.
Geng  SLei  XToyohara  JP  et al.  Stiff skin syndrome. J Eur Acad Dermatol Venereol 2006;20 (6) 729- 732
PubMedArticle
22.
Odom  RBJames  WDBerger  TG Scleredema. Odom  RBJames  WDBerger  TGDiseases of the Skin: Clinical Dermatology 9th ed. Philadelphia, PA WB Saunders Co2000;207- 209
23.
Cole  HGWinkelmann  RK Acid mucopolysaccharide staining in scleredema. J Cutan Pathol 1990;17 (4) 211- 213
PubMedArticle
24.
Venencie  PYPowell  FCSu  WPDPerry  HO Scleredema: a review of thirty-three cases. J Am Acad Dermatol 1984;11 (1) 128- 134
PubMedArticle
25.
Farrell  AMBranfoot  ACMoss  J  et al.  Scleredema diabeticorum of Buschke confined to the thighs. Br J Dermatol 1996;134 (6) 1113- 1115
PubMedArticle
26.
Dogra  SHanda  SKanwar  AJ Dexamethasone pulse therapy for scleredema. Pediatr Dermatol 2004;21 (3) 280- 281
PubMedArticle
27.
Ioannidou  DIKrasagakis  KStefanidou  MP  et al.  Scleredema adultorum of Buschke presenting as periorbital edema: a diagnostic challenge. J Am Acad Dermatol 2005;52 (2) ((suppl 1)) 41- 44
PubMedArticle
28.
Vereecken  PLutz  RDe Dobbeleer  GHeenen  M Nonpitting induration of the back. Arch Dermatol 1997;133 (5) 649- 654
PubMedArticle
29.
Bowen  ARSmith  LZone  JJ Scleredema adultorum of Buschke treated with radiation. Arch Dermatol 2003;139 (6) 780- 784
PubMedArticle
30.
García-Patos  VBartralot  RFonollosa  V  et al.  Childhood sclerodermatomyositis: report of a case with anti PM/Scl antibody and mechanic's hands. Br J Dermatol 1996;135 (4) 613- 616
PubMedArticle
31.
Albrecht  S Smooth muscle hamartoma. Freedberg  IMEisen  AZWolff  KFitzpatrick's Dermatology in General Medicine 5th ed. New York, NY McGraw-Hill1999;1210- 1211
32.
Odom  RBJames  WDBerger  TG Connective tissue nevi. Odom  RBJames  WDBerger  TGDiseases of the Skin: Clinical Dermatology 9th ed. Philadelphia, PA WB Saunders Co2000;768- 769
33.
From  LAssaad  D Connective tissue nevus. Freedberg  IMEisen  AZWolff  KFitzpatrick's Dermatology in General Medicine 5th ed. New York, NY McGraw-Hill1999;1165- 1166
34.
Jan  FSegal  JMDyer  J  et al.  Nephrogenic fibrosing dermopathy: two pediatric cases. J Pediatr 2003;143 (5) 678- 681
PubMedArticle
35.
Marckmann  PSkov  LRossen  K  et al.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17 (9) 2359- 2362
PubMedArticle
36.
High  WAAyers  RAChandler  J  et al.  Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007;56 (1) 21- 26
PubMedArticle
37.
Torres  VMGeorge  WM Diffuse eosinophilic fasciitis: a new syndrome or variant of scleroderma? Arch Dermatol 1977;113 (11) 1591- 1593
PubMedArticle
38.
Maddison  PJ Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis. Ann Rheum Dis 1991;50 ((suppl 4)) 887- 893
PubMedArticle
39.
Lakhanpal  SGinsburg  WWMichet  CJDoyle  JAMoore  SB Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17 (4) 221- 231
PubMedArticle
40.
Muenzer  J Mucopolysaccharidoses. Adv Pediatr 1986;33269- 302
PubMed
41.
Sybert  VP Stiff skin. Sybert  VPGenetic Skin Disorders New York, NY Oxford University Press1997;481- 483
42.
Beck  MBarone  RHoffman  R  et al.  Inter- and intrafamilial variability in mucolipidosis II (I-cell disease). Clin Genet 1995;47 (4) 191- 199
PubMedArticle
43.
Kudo  MBrem  MSCanfield  WM Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha/beta-subunits precursor gene. Am J Hum Genet 2006;78 (3) 451- 463
PubMedArticle
44.
Chanoki  MIshii  MFukai  K  et al.  Farber's lipogranulomatosis in siblings: light and electron microscopic studies. Br J Dermatol 1989;121 (6) 779- 785
PubMedArticle
45.
Glover  MTLake  BDAtherton  DJ Infantile systemic hyalinosis: newly recognized disorder of collagen? Pediatrics 1991;87 (2) 228- 234
PubMed
46.
Sahn  EESalinas  CFSens  MA  et al.  Infantile systemic hyalinosis in a black infant. Pediatr Dermatol 1994;11 (1) 52- 60
PubMedArticle
47.
Glover  MTLake  BDAtherton  DJ Clinical, histologic, and ultrastructural findings in two cases of infantile systemic hyalinosis. Pediatr Dermatol 1992;9 (3) 255- 258
PubMedArticle
48.
Hanks  SAdams  SDouglas  J  et al.  Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 2003;73 (4) 791- 800
PubMedArticle
49.
Dowling  ODifeo  ARamirez  MC  et al.  Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 2003;73 (4) 957- 966
PubMedArticle
50.
Mancini  GMSStojanov  LWillemsen  R  et al.  Juvenile hyaline fibromatosis: clinical heterogeneity in three patients. Dermatology 1999;198 (1) 18- 25
PubMedArticle
51.
Happle  RSchuurmans Stekhoven  HHamel  BCJ  et al.  Restrictive dermopathy in two brothers. Arch Dermatol 1992;128 (2) 232- 235
PubMedArticle
52.
Welsh  KMSmoller  BRHolbrook  KAJohnston  K Restrictive dermopathy. Arch Dermatol 1992;128 (2) 228- 231
PubMedArticle
53.
Nijsten  TECDe Moor  AColpaert  CG  et al.  Restrictive dermopathy: a case report and a critical review of all hypotheses of its origin. Pediatr Dermatol 2002;19 (1) 67- 72
PubMedArticle
54.
Navarro  CLDe Sandre-Giovannoli  ABernard  R  et al.  Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 2004;13 (20) 2493- 2503
PubMedArticle
55.
Navarro  CLCadinanos  JDe Sandre-Giovannoli  A  et al.  Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of lamin A precursors. Hum Mol Genet 2005;14 (11) 1503- 1513
PubMedArticle
56.
Kan  AERogers  M Juvenile hyaline fibromatosis: an expanded clinicopathologic spectrum. Pediatr Dermatol 1989;6 (2) 68- 75
PubMedArticle
57.
Erdem  NGunes  ATAvci  OOsma  E A Case of Hutchinson-Gilford progeria syndrome mimicking scleredema in early infancy. Dermatology 1994;188 (4) 318- 321
PubMedArticle
58.
Sybert  VP Hutchinson-Gilford progeria. Sybert  VPGenetic Skin Disorders New York, NY Oxford University Press1997;567- 570
59.
Glynn  MWGlover  TW Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet 2005;14 (20) 2959- 2969
PubMedArticle
60.
Spranger  JWGilbert  EFTuffli  GAPossiter  FPOpitz  JM Geleophysic dwarfism—a “focal” mucopolysaccharidosis. Lancet 1971;2 (7715) 97- 98
PubMedArticle
61.
Spranger  JGilbert  EFArya  SHoganson  GMIOpitz  JM Geleophysic dysplasia. Am J Med Genet 1984;19 (3) 487- 499
PubMedArticle
62.
Shohat  MGruber  HEPagon  RA  et al.  Geleophysic dysplasia: a storage disorder affecting the skin, bone, liver, heart, and trachea. J Pediatr 1990;117 (2, pt 1) 227- 232
PubMedArticle
63.
Pontz  BFStob  HHenschke  F  et al.  Clinical and ultrastructural findings in three patients with geleophysic dysplasia. Am J Med Genet 1996;63 (1) 50- 54
PubMedArticle
64.
Santolaya  JMGroninga  LCDelgado  A  et al.  Patients with geleophysic dysplasia are not always geleophysic. Am J Med Genet 1997;72 (1) 85- 90
PubMedArticle
65.
Cohen  AHHollister  DWReed  WB The skin in Winchester syndrome. Arch Dermatol 1975;111 (2) 230- 236
PubMedArticle
66.
Winter  RM Winchester syndrome. J Med Genet 1989;26 (12) 772- 775
PubMedArticle
67.
Sidwell  RUBrueton  LAGrabczynska  SA  et al.  Progressive multilayered banded skin in Winchester syndrome. J Am Acad Dermatol 2004;50 (2) ((suppl)) S53- S56
PubMedArticle
68.
Fretzin  DFAria  AM Sclerema neonatorum and subcutaneous fat necrosis of the newborn. Pediatr Dermatol 1987;4 (2) 112- 122
PubMedArticle
69.
Cat  IMagdalena  NIRMarinoni  LP  et al.  Parana hard-skin syndrome: study of seven families [letter]. Lancet 1974;1 (7850) 215- 216
PubMedArticle
70.
Pereyo  NGHeimer  WM Extraabdominal desmoid tumor. J Am Acad Dermatol 1996;34 (2, pt 2) 352- 356
PubMedArticle
71.
Schmidt  D Fibrous tumors and tumor-like lesions of childhood: diagnosis, differential diagnosis, and prognosis. Curr Top Pathol 1995;89175- 191
PubMed
72.
Menton  DNHess  RALichtenstein  JREisen  AZ The structure and tensile properties of the skin of tight-skin (Tsk) mutant mice. J Invest Dermatol 1978;70 (1) 4- 10
PubMedArticle
73.
Jimenez  SAMillan  ABashey  RI Scleroderma-like alterations in collagen metabolism occurring in the tsk (tight skin) mouse. Arthritis Rheum 1984;27 (2) 180- 185
PubMedArticle
×